Hikma 503B is an FDA-registered outsourced sterile compounding business focused on providing quality, ready-to-administer injectable medications that are customized to the specific needs of US patients. Hikma 503B builds on the Hikma group’s expertise and position as a supplier of injectable medicines to US hospitals with a strong reputation for quality and reliability. Aiming to provide hospitals with a reliable source of quality compounded sterile preparations, Hikma 503B has two facilities in New Jersey which are registered with and have been inspected by the FDA.